These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30950170)

  • 1. Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy.
    Polyzos SA; Kountouras J
    Helicobacter; 2019 Jun; 24(3):e12588. PubMed ID: 30950170
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?
    Polyzos SA; Kountouras J; Mantzoros CS
    Metabolism; 2019 Jul; 96():iii-v. PubMed ID: 31121179
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study.
    Polyzos SA; Nikolopoulos P; Stogianni A; Romiopoulos I; Katsinelos P; Kountouras J
    Arq Gastroenterol; 2014; 51(3):261-8. PubMed ID: 25296089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease and
    Polyzos SA; Kountouras J
    Curr Vasc Pharmacol; 2023; 21(2):78-80. PubMed ID: 36757013
    [No Abstract]   [Full Text] [Related]  

  • 5. Helicobacter pylori and non-alcoholic fatty liver disease.
    Buzás GM
    Minerva Gastroenterol Dietol; 2020 Sep; 66(3):267-279. PubMed ID: 32724031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease.
    Tang DM; Kumar S
    Curr Gastroenterol Rep; 2017 Feb; 19(2):5. PubMed ID: 28155087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease.
    Li M; Shen Z; Li YM
    World J Gastroenterol; 2013 Nov; 19(41):7024-31. PubMed ID: 24222944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial.
    Yu YY; Tong YL; Wu LY; Yu XY
    Sci Rep; 2022 Nov; 12(1):19530. PubMed ID: 36376474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori.
    Abenavoli L; Milic N; Masarone M; Persico M
    Med Hypotheses; 2013 Nov; 81(5):913-5. PubMed ID: 24011768
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Okushin K; Tsutsumi T; Ikeuchi K; Kado A; Enooku K; Fujinaga H; Moriya K; Yotsuyanagi H; Koike K
    World J Gastroenterol; 2018 Aug; 24(32):3617-3625. PubMed ID: 30166857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori infection, insulin resistance and nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Zavos C; Deretzi G
    Med Hypotheses; 2014 Jun; 82(6):795. PubMed ID: 24685365
    [No Abstract]   [Full Text] [Related]  

  • 12. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.
    Kim TJ; Sinn DH; Min YW; Son HJ; Kim JJ; Chang Y; Baek SY; Ahn SH; Lee H; Ryu S
    J Gastroenterol; 2017 Nov; 52(11):1201-1210. PubMed ID: 28382402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of Helicobacter pylori eradication on the metabolic syndrome components].
    Chopeĭ IV; Mykhalko IaO; Chubirko KI; Hechko MM; Varvarynets' AV; Khanenko SS; Kanchiĭ VM
    Wiad Lek; 2014; 67(2 Pt 2):226-9. PubMed ID: 25796832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery disease and Helicobacter pylori infection: Should we consider eradication therapy as cardiovascular prevention strategy?
    Zuin M; Rigatelli G; Del Favero G; Picariello C; Meggiato T; Conte L; Faggian G; Zuliani G; Roncon L
    Int J Cardiol; 2016 Nov; 223():711-712. PubMed ID: 27573593
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of Helicobacter pylori eradication on iron deficiency.
    Zhang ZF; Yang N; Zhao G; Zhu L; Zhu Y; Wang LX
    Chin Med J (Engl); 2010 Jul; 123(14):1924-30. PubMed ID: 20819579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma?
    Abdel-Razik A; Mousa N; Shabana W; Refaey M; Elhelaly R; Elzehery R; Abdelsalam M; Elgamal A; Nassar MR; Abu El-Soud A; Seif AS; Tawfik AM; El-Wakeel N; Eldars W
    Helicobacter; 2018 Dec; 23(6):e12537. PubMed ID: 30246507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type B insulin resistance syndrome with Scleroderma successfully treated with multiple immune suppressants after eradication of Helicobacter pylori infection: a case report.
    Yang GQ; Li YJ; Dou JT; Wang BA; Lu JM; Mu YM
    BMC Endocr Disord; 2016 May; 16(1):20. PubMed ID: 27142369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update: is there a relationship between
    Chen X; Peng R; Peng D; Xiao J; Liu D; Li R
    Front Cell Infect Microbiol; 2023; 13():1282956. PubMed ID: 38145041
    [No Abstract]   [Full Text] [Related]  

  • 19. Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease.
    Baeg MK; Yoon SK; Ko SH; Noh YS; Lee IS; Choi MG
    World J Gastroenterol; 2016 Feb; 22(8):2592-600. PubMed ID: 26937147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Helicobacter pylori resistance after failure of first-line therapy. A systematic review.
    Muñoz N; Sánchez-Delgado J; Baylina M; López-Góngora S; Calvet X
    Gastroenterol Hepatol; 2018 Dec; 41(10):654-662. PubMed ID: 30180998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.